Hims & Hers Brings First-Time Access to Generic Semaglutide to Canada

Go back to Hims & Hers Brings First-Time Access to Generic Semaglutide to Canada
(NYSE: HIMS) Delayed: 33.57 -1.9 (5.36%)
Previous Close $35.47    52 Week High
Open $34.63    52 Week Low
Day High $35.99    P/E N/A 
Day Low $33.41    EPS
Volume 14,588,065